Brought to you by:
![Vascular Specialist [LIVE]](https://vascularspecialistonline.com/wp-content/uploads/2026/08/vascular_specialist_logo_forwebsite_new.png){kind=logo}
MDR certification secured for Impede embolization plug devices
Shape Memory Medical announced that its Impede embolization plug product family has received certification as a Class III device under the European Union (EU) Medical Device Regulation (MDR) 2017 The Impede devices, previously CE-marked under the Medical Device Directive 93/42/EEC…
Shape Memory Medical announces midway milestone in AAA-SHAPE randomised controlled pivotal trial
Shape Memory Medical has reached 50 per cent enrolment in its ongoing AAA-SHAPE pivotal trial, the company announced last week. AAA-SHAPE is a prospective, multicenter, randomized, open-label trial to determine safety and effectiveness of the Impede-FX RapidFill device to improve…
Shape Memory Medical completes enrollment in EMBO-PMS registry
Shape Memory Medical today announced the completion of patient enrollment in the EMBO postmarket surveillance (EMBO-PMS) registry, the company’s prospective, multicenter registry of the Impede and Impede-FX embolisation plugs, and Impede-FX RapidFill device when used for peripheral vascular embolization. A…
Shape Memory Medical announces first European enrolment in AAA-SHAPE pivotal trial
Shape Memory Medical today announced the first European enrollment in the AAA-SHAPE pivotal trial, the company’s prospective, multicenter, randomized, open-label trial to determine the safety and effectiveness of the Impede-FX RapidFill device to improve abdominal aortic aneurysm (AAA) sac behavior…
Shape Memory Medical announces first patient treated in the AAA-SHAPE randomised controlled pivotal trial
Shape Memory Medical recently announced that the first patient has been treated in the AAA-SHAPE pivotal trial. AAA-SHAPE (Abdominal aortic aneurysm sac healing and prevention of expansion) is a prospective, multicentre, randomised, open-label trial to determine safety and effectiveness of…